IPO registrations (S-1, F-1) · Registrants
ORAGENICS INC
- SEC CIK
- 1174940 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2010-08-25, last 2025-06-30; 7 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2018-07-13; declared effective 2012-09-26; withdrawal requested 2010-12-22
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- FL
- Business address
- 9015 TOWN CENTER PARKWAY, SUITE 143, Lakewood Ranch, FL 34202
- EIN
- 59-3410522
- Ticker
- OGEN (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ORAGENICS INC on the corporate pages
Offering terms
- Final price
- $1.00 per share (424B4 filed 2018-07-13)
- Shares sold
- 2,636,000
- Gross proceeds
- $2,636,000 before underwriting discounts and any over-allotment option
- Listing
- NYSE American under the symbol OGEN
- Lead underwriters
- Ladenburg Thalmann
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ORAGENICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Federal award recipient: ORAGENICS, INC Fuzzy (name and state)
- Form D issuer: ORAGENICS INC EXACT (CIK (EXACT))
- Lobbying client: ORAGENICS, INC Fuzzy (name and state)
- Lobbying client: ORAGENICS, INC. Fuzzy (name and state)
- Lobbying client: ORAGENICS, INC. Fuzzy (name and state)
- SEC filer: ORAGENICS INC EXACT (CIK (EXACT))
- Person page: Christine L Koski Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other))
- Person page: Richard T Welch Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Robert C Koski Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Thomas L Koski Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other))
Filings 33
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-08-25 | S-1 | S-1 (registration) | ORAGENICS INC | 0001193125-10-195955 ↗ |
| 2010-10-05 | S-1/A | S-1/A (amendment) | ORAGENICS INC | 0001193125-10-223966 ↗ |
| 2010-12-22 | RW | RW (withdrawal request) | ORAGENICS INC | 0001193125-10-286393 ↗ |
| 2012-08-31 | S-1 | S-1 (registration) | ORAGENICS INC | 0001193125-12-377645 ↗ |
| 2012-09-21 | S-1/A | S-1/A (amendment) | ORAGENICS INC | 0001193125-12-400063 ↗ |
| 2012-09-26 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-12-002825 ↗ |
| 2013-05-02 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-13-001372 ↗ |
| 2013-08-26 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-13-002518 ↗ |
| 2016-09-07 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-16-005632 ↗ |
| 2018-04-27 | S-1 | S-1 (registration) | ORAGENICS INC | 0001193125-18-139099 ↗ |
| 2018-05-08 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-18-001174 ↗ |
| 2018-05-15 | S-1 | S-1 (registration) | ORAGENICS INC | 0001193125-18-164253 ↗ |
| 2018-07-05 | S-1/A | S-1/A (amendment) | ORAGENICS INC | 0001193125-18-213187 ↗ |
| 2018-07-09 | S-1/A | S-1/A (amendment) | ORAGENICS INC | 0001193125-18-213992 ↗ |
| 2018-07-11 | S-1/A | S-1/A (amendment) | ORAGENICS INC | 0001193125-18-216127 ↗ |
| 2018-07-12 | S-1MEF | S-1MEF (added securities) | ORAGENICS INC | 0001193125-18-216974 ↗ |
| 2018-07-12 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-18-001773 ↗ |
| 2018-07-13 | 424B4 | 424B4 (final prospectus) | ORAGENICS INC | 0001193125-18-217823 ↗ |
| 2020-01-13 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-20-000082 ↗ |
| 2020-06-30 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-20-001679 ↗ |
| 2023-01-25 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-23-000184 ↗ |
| 2024-08-16 | S-1 | S-1 (registration) | ORAGENICS INC | 0001493152-24-032843 ↗ |
| 2024-09-03 | S-1/A | S-1/A (amendment) | ORAGENICS INC | 0001493152-24-034815 ↗ |
| 2024-09-03 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-24-002706 ↗ |
| 2024-12-18 | S-1 | S-1 (registration) | ORAGENICS INC | 0001493152-24-050649 ↗ |
| 2024-12-31 | S-1/A | S-1/A (amendment) | ORAGENICS INC | 0001493152-24-052623 ↗ |
| 2025-01-08 | S-1/A | S-1/A (amendment) | ORAGENICS INC | 0001493152-25-001268 ↗ |
| 2025-01-16 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-25-000132 ↗ |
| 2025-02-04 | RW | RW (withdrawal request) | ORAGENICS INC | 0001493152-25-004852 ↗ |
| 2025-06-23 | S-1 | S-1 (registration) | ORAGENICS INC | 0001641172-25-015984 ↗ |
| 2025-06-30 | S-1/A | S-1/A (amendment) | ORAGENICS INC | 0001641172-25-017088 ↗ |
| 2025-06-30 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-25-002103 ↗ |
| 2026-03-20 | EFFECT | EFFECT (declared effective) | ORAGENICS INC | 9999999995-26-000882 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-07-11 | S-1/A | registration statement | $2.00 | 1,470,588 | $2,941,176 | NYSE American OGEN | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ | |
| 2018-07-13 | 424B4 | final prospectus | $1.00 | 2,636,000 | $2,636,000 | NYSE American OGEN | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ANDERSON BRIAN | Director | 1 | 2006 | ||
| GURY DAVID J | Director | 4 | 2006–2008 | ||
| HAWES GEORGE T | Director,TenPercentOwner; TenPercentOwner | 31 | 2006–2010 | ||
| HILLMAN JEFFREY D | Director,Officer; Director,Officer,TenPercentOwner | Chief Scientific Officer; Chief Scientific Officer /; Director | 15 | 2006–2011 | |
| Zahradnik Robert T | Director,Officer; Officer; Other | Chief Operating Officer; PLEASE PROVIDE; President and CEO | 9 | 2006–2009 | |
| Delfino Dorothy Jean | Officer | CFO AND SECRETARY | 3 | 2007–2008 | |
| Evens Ronald P | Director; Director,Officer | CEO & President | 4 | 2007–2008 | |
| Hennecke Derek | Director | 3 | 2008 | ||
| Welch Richard T. | Director | 3 | 2008 | person page Fuzzy | |
| Stein Stanley Bruce | Director; Director,Officer | President & CEO | 3 | 2008 | |
| Sills Kevin H | Director | 3 | 2008 | ||
| Siegel Marc K | Director | 3 | 2008 | ||
| Hirsch David Brian | Director,Officer; Officer | COO and CFO; President and CEO | 3 | 2008–2009 | |
| Bohunicky Brian John | Officer | CFO, Secretary and Treasurer; Chief Financial Officer | 7 | 2009–2011 | |
| KOSKI BEVERLY | Other; TenPercentOwner | 56 | 2009–2019 | ||
| KOSKI CHRISTINE L | Director,TenPercentOwner; Other; TenPercentOwner | 57 | 2009–2019 | person page Fuzzy | |
| KOSKI FAMILY LP | Director,TenPercentOwner; Other; TenPercentOwner | 57 | 2009–2019 | ||
| KOSKI ROBERT C | Director; Director,TenPercentOwner; TenPercentOwner | 74 | 2009–2025 | person page Fuzzy | |
| KOSKI THOMAS L | Other; TenPercentOwner | 56 | 2009–2019 | person page Fuzzy | |
| POPE CHARLES L | Director | 24 | 2010–2025 | ||
| Telling Fred | Director | 43 | 2010–2026 | ||
| DUNTON ALAN W | Director | 36 | 2011–2025 | ||
| BONFIGLIO JOHN N | Director,Officer | President and CEO | 10 | 2011–2014 | |
| Sullivan Michael O'Keefe | Officer | CFO, Secretary and Treasurer; Chief Financial Officer; Interim PEO, CFO; See Remarks | 17 | 2012–2022 | |
| INTREXON CORP | TenPercentOwner | 7 | 2012–2016 | ||
| KIRK RANDAL J | TenPercentOwner | 7 | 2012–2016 | ||
| Joslyn Alan | Director,Officer | CEO and President; See Remarks | 9 | 2016–2021 | |
| Murphy Kimberly M | Director; Director,Officer | CEO and President | 7 | 2020–2024 | |
| Hernandez Joseph | TenPercentOwner | 3 | 2020–2021 | ||
| Huffman Janet | Officer | CEO and CFO; CFO, Secretary and Treasurer; Chief Financial Officer | 5 | 2023–2025 | |
| Cassidy Bruce A. Sr. | Director | 3 | 2023–2024 | ||
| GANDOLFO JOHN P | Director | 4 | 2023–2025 | ||
| REDMOND J MICHAEL | Officer | President | 3 | 2024 | |
| Odyssey Health, Inc. | TenPercentOwner | 3 | 2025 | ||
| Giordano Natasha | Director | 2 | 2025 | ||
| Spencer John | Officer | Chief Financial Officer | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2023-08-08 | ORAGENICS INC | Biotechnology | $850,000 | $850,000 | 2 | 1 |
| 2020-05-06 | ORAGENICS INC | Biotechnology | Indefinite | $4,600,000 | 1 | 1 |
| 2018-04-12 | ORAGENICS INC | Biotechnology | $1,800,000 | $1,800,000 | 2 | 1 |
| 2017-11-14 | ORAGENICS INC | Biotechnology | $6,676,209 | $6,676,209 | 5 | 1 |
| 2017-05-19 | ORAGENICS INC | Biotechnology | $3,000,000 | $1,302,292 | 3 | 1 |
| 2016-07-13 | ORAGENICS INC | Biotechnology | $4,666,666 | $4,666,666 | 3 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ORAGENICS, INC. | FL | State business registries | name and state |
| Federal award recipient | ORAGENICS, INC | FL | Federal spending (USAspending) | name and state |
| Form D issuer | ORAGENICS INC | FL | Form D private offerings | CIK (EXACT) |
| Lobbying client | ORAGENICS, INC | FL | Federal lobbying (LDA) | name and state |
| Lobbying client | ORAGENICS, INC. | FL | Federal lobbying (LDA) | name and state |
| Lobbying client | ORAGENICS, INC. | FL | Federal lobbying (LDA) | name and state |
| Patent assignee | Oragenics, Inc | FL | Patents (USPTO) | name and state |
| SEC filer | ORAGENICS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Oragenics, Inc. | FL | Trademarks (USPTO) | name and state |
| Person page | Christine L Koski | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other) | |
| Person page | Richard T Welch | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Robert C Koski | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Thomas L Koski | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, FL first:
- SANO CORP FL
- CTT PHARMACEUTICAL HOLDINGS, INC. FL
- Inhibitor Therapeutics, Inc. FL
- GENEREX BIOTECHNOLOGY CORP FL
- BIOMOLECULAR LIFE HOLDINGS, INC. FL
- Alaunos Therapeutics, Inc. FL
- Polomar Health Services, Inc. FL
- ACCENTIA BIOPHARMACEUTICALS INC FL
- NOMAD POWER SOLUTIONS, INC. FL
- CATALYST PHARMACEUTICALS, INC. FL
In other datasets, the same topic (Health) in FL:
- Nonprofit: 414 WELLWOMEN INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health